Overview
Paradigm Health has acquired Flatiron Health's clinical research business, enhancing its tech-enabled oncology research network. The collaboration aims to improve access to clinical trials for over 2.4 million patients across the U.S. Terms of the deal were not disclosed, but it strengthens ties with 15 of the top 20 global biopharma companies.
Products
Loading...
Recent Deals
Paradigm Health has acquired Flatiron Health's clinical research business, enhancing its tech-enabled oncology research network. The collaboration aims to improve access to clinical trials for over 2.4 million patients across the U.S. Terms of the deal were not disclosed, but it strengthens ties with 15 of the top 20 global biopharma companies.